Geftiget Tablets 250mg
Couldn't load pickup availability
You can promote by sharing on social networks on the links.
Product Description
Geftiget Tablets 250mg contains Gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used to treat EGFR mutation-positive non-small cell lung cancer (NSCLC). It helps slow or stop the growth of cancer cells by blocking EGFR signaling.
Product Overview
Product Name: Geftiget Tablets 250mg
Generic Name: Gefitinib
Strength: 250mg
Form: Tablets
Pack Size: As per manufacturer packaging
Used For: Treatment of EGFR-positive non-small cell lung cancer
Prescription Required: Yes
Ingredients & How They Work
Each tablet contains Gefitinib 250mg, which inhibits the epidermal growth factor receptor (EGFR) tyrosine kinase, preventing cancer cells from growing and multiplying.
Key Benefits
- Treats EGFR-positive non-small cell lung cancer
- Helps slow cancer progression
- Targeted oral anticancer therapy
- Once-daily tablet formulation
- Supports long-term cancer management
How to Use
Take exactly as prescribed by your oncologist. Swallow the tablet whole with water, with or without food, at the same time each day.
Side Effects & Precautions
Possible Side Effects
- Skin rash
- Diarrhea
- Dry skin
- Nausea
- Loss of appetite
Precautions
- Use only under specialist supervision.
- Regular liver function tests may be required.
- Report any breathing difficulties immediately.
- Inform your doctor about all medications you are taking.
Storage Instructions
Store below 30°C in a cool, dry place away from moisture and direct sunlight.